FibroGen, Inc. (LON:0IL8)
0.677
-0.146 (-17.71%)
At close: Feb 21, 2025
FibroGen Employees
FibroGen had 486 employees as of December 31, 2023. The number of employees decreased by 106 or -17.91% compared to the previous year.
Employees
486
Change (1Y)
-106
Growth (1Y)
-17.91%
Revenue / Employee
276.36K GBP
Profits / Employee
-186.97K GBP
Market Cap
56.27M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
GSK plc | 70,212 |
Haleon | 25,408 |
Smith & Nephew | 18,452 |
Hikma Pharmaceuticals | 9,100 |
ConvaTec Group | 10,136 |
HUTCHMED (China) | 1,988 |
Oxford Nanopore Technologies | 1,238 |
FibroGen News
- 2 months ago - FibroGen started at buy by H.C. Wainwright - Seeking Alpha
- 2 months ago - FibroGen appoints David DeLucia CFO - Seeking Alpha
- 2 months ago - FibroGen Appoints David DeLucia as Chief Financial Officer - GlobeNewsWire
- 3 months ago - FibroGen, Inc. (FGEN) Q3 2024 Earnings Conference Call Transcript - Seeking Alpha
- 3 months ago - FibroGen Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - FibroGen to Report Third Quarter 2024 Financial Results - GlobeNewsWire
- 7 months ago - FibroGen, Inc. (FGEN) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 7 months ago - One Year, Five Trial Failures: FibroGen Terminates Pancreatic Cancer Treatment Program - Benzinga